
Recombinetics is a leading company specializing in animal gene editing technologies for biomedical research and animal agriculture. Founded in 2008, it offers custom gene-edited swine models to accelerate preclinical research and reduce reliance on nonhuman primates. The company integrates advanced molecular tools, artificial intelligence, and expertise in bioinformatics, cell engineering, and stem cell biology to develop innovative gene-edited animals and products. Recombinetics holds a broad global patent portfolio covering gene editing methods for non-human species and has pioneered multiple firsts in gene editing for biomedicine and agriculture. Its business model includes providing gene-edited animal models and preclinical services, positioning it for rapid growth in biomedical and food animal markets.

Recombinetics is a leading company specializing in animal gene editing technologies for biomedical research and animal agriculture. Founded in 2008, it offers custom gene-edited swine models to accelerate preclinical research and reduce reliance on nonhuman primates. The company integrates advanced molecular tools, artificial intelligence, and expertise in bioinformatics, cell engineering, and stem cell biology to develop innovative gene-edited animals and products. Recombinetics holds a broad global patent portfolio covering gene editing methods for non-human species and has pioneered multiple firsts in gene editing for biomedicine and agriculture. Its business model includes providing gene-edited animal models and preclinical services, positioning it for rapid growth in biomedical and food animal markets.